Cladribine tablet for those with active multiple sclerosis will reduce hospital visits and free up appointments
Thousands of patients with multiple sclerosis (MS) in England are to become the first in Europe to benefit from a major roll out of an immunotherapy pill.
Current treatments involve regular trips to hospital, drug infusions, frequent injections and extensive monitoring, which add to the burden on patients and healthcare systems.
More Stories
Sperm from cancer-risk donor used to conceive at least 67 children across Europe
The latest twist in a Canadian medical mystery – podcast
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip